Looking to publish in Cancer Letters? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCancer Letters is an international journal providing a forum for original and pertinent contributions in cancer research. It considers full-length articles and Mini Reviews in the broad area of basic and translational oncology, with special issues highlighting topical areas in cancer research. Areas of interest include molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, chemoprevention, and experimental therapeutics including targeted therapies for personalized cancer medicine.
Looking to publish in Cancer Letters? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Cancer Letters accepts the following article types. Click on an article type to view submission instructions.
Original Research Articles
Review Articles
Mini Reviews
Short Articles
Letters To The Editor
Research Letters
Recent Publications
Reactive oxygen species define leukemia stem cell identity in pediatric acute myeloid leukemia
Maddalena Benetton, Ambra Da Ros, Alberto Peloso, Giorgia Longo, Sara Perpinello, Chiara Frasson, Tiago Branco Fonseca, Elena Varotto, Silvia Bresolin, Claudia Tregnago, Luca Scorrano, Benjamin J. Huang, Soheil Meshinchi, Franco Locatelli, Martina Pigazzi
Targeting the Metabolic-Immune Regulator SLC35F6 Enhances Temozolomide and Anti-PD-L1 Therapy in Glioma
Pengpeng Lu, Wei Wang, Bing Lu, Shijie Xu, Feng Wang, Liang Han, Ziheng Wang, Jianfei Huang
When RNA Wears a Sugar Coat: Emerging Biology and Cancer Relevance of GlycoRNA
Tingju Ren, Zhuoqun Lin, Wenrui Xie, Ruizi Peng, Lingfang Wang
Targeting p300/CBP destabilizes HIF-2α and suppresses tumor growth in cell and animal models of clear cell renal cell carcinoma
Rushaniya Fazliyeva, Alexey Matveev, Ruslan Smetanin, Ilia Fedorov, Kathy Q. Cai, Alexander Kutikov, Robert G. Uzzo, Andrew Andrews, Peter Makhov, Vladimir M. Kolenko
Rapid Manufactured CAR-T Cells enriched for CD45RA-negative T cells Exhibit Superior Persistence Compared to Conventional CAR-T Therapy
Xuying Pei, Meng Lv, Xiaozheng Zhao, Zhuojun Liu, Luhan Deng, Zhipeng Zhou, Yanping Ding, Jing Liu, Leping Zhang, Qian Jiang, Xiaohui Zhang, Xinan Lu, Ting He, Xiaojun Huang, Xiangyu Zhao
Frequently asked questions
How long does it take to publish?
3 days from submission to first decision; 30 days from submission to decision after review; 92 days from submission to acceptance; 2 days from acceptance to first online publication for papers published online.
Reformat to Cancer Letters using Livewrite PremiumWhat are the publication costs?
Open Access APC: USD 4,710 excluding taxes. Subscription option: no publication fee charged to authors.
Reformat to Cancer Letters using Livewrite Premium